QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psyched-elon-musk-tweets-about-psychedelics-numinus-acquires-novamind-colorado-gov-signs-mdma-legalization-bill

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelic...

 largest-phase-1-dmt-study-in-the-netherlands-a-collaboration-between-entheon--cybin

Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has enter...

 benzingas-unprecedented-psychedelics-investing-conference-lands-in-miami-on-april-19th

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking...

 psychedelics-biotech-startup-launches-phase-1-study-on-ayahuascas-active-ingredient

Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics com...

 psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

 entheon-biomedical-corp-strengthens-its-psychedelic-assisted-protocols-through-acquisition-of-lobo-genetics

Psychedelics biotech company Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:1XU1) has acquired Lobo Genetics Inc., a ...

 psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

 psyched-atai-life-sciences-hits-nasdaq-canada-to-fund-ketamine-trials-mydecine-launches-ai-drug-discovery-platform

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.

 first-psychedelics-etf-debuts-on-neo-exchange

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first ex...

 psyched-compass-launches-center-of-excellence-entheon-purchases-halugen-atai-buys-majority-stake-in-recognify

Compass Launches Center Of Excellence Compass Pathways (NASDAQ: CMPS) officially launched the Centre of Excellence, in collabo...

 2020-was-the-year-of-psychedelics--heres-why

While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics. There was unprecede...

 psyched-canada-allows-psilocybin-use-for-healthcare-pros-uk-begins-dmt-trials-cybin-to-purchase-adelia

Canada Allows Professionals In Training To Use Psilocybin The Canadian Health Minister Patty Hajdu has allowed 17 healthcare p...

 imperial-college-of-london-to-study-illegal-psychedelic-compound-in-first-ever-clinical-trial

Clinical trials on the hallucinogenic drug DMT for the treatment of depression are expected to start in January.

 psyched-numinus-maps-to-spearhead-mdma-trials-vancouver-plans-to-decriminalize-drugs

Numinus and MAPS Collaborate to Study MDMA in Canada Numinus Wellness (TSXV: NUMI) and the MAPS Public Benefit Corporation hav...

 psyched-ca-discusses-decriminalization-compass-holds-earnings-call-psychedelics-hotline-to-launch

California’s legislature could soon be discussing a new bill meant to decriminalize psychedelic substances.